| Dr Kevin J Grady, MD | |
|
25319 Little Mack Ave, Saint Clair Shores, MI 48081-3370 | |
| (586) 772-5550 | |
| (586) 772-1706 |
| Full Name | Dr Kevin J Grady |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 43 Years |
| Location | 25319 Little Mack Ave, Saint Clair Shores, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821013723 | NPI | - | NPPES |
| 1762697 | Medicaid | MI | |
| 0E00425 | Other | MI | BLUE CROSS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 4301049952 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension St John Hospital | Detroit, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pulmonary And Critical Care Associates Pc | 0547250607 | 22 |
News Archive
BioCryst Pharmaceuticals, Inc. announced the presentation of new data that confirms forodesine's clinical activity in the treatment of chronic lymphocytic leukemia at the 52nd Annual American Society of Hematology Meeting & Exposition being held in Orlando, Florida.
A government report says that clinical trials for new medicines are taking too long and should be sped up so patients can access urgently needed treatment. The states and territories have been urged to adopt uniform rules on approving trials so the scientific experiments can be conducted more efficiently and effectively.
The states need to increase the number of public dental patients they treat or lose the reward payments offered by the federal government under its new $500 million dental package. A total of over $800 million of new money has come into the focal points of the health budget - dental and aged care.
Merck & Co., Inc., known outside the U.S. and Canada as MSD, today provided further detail on integration plans for the company's research and development, manufacturing and other business operations as part of a global restructuring program announced following the November 2009 merger of Merck and Schering-Plough.
A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.
› Verified 1 days ago
| Entity Name | Ascension St John Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043478910 PECOS PAC ID: 3173424082 Enrollment ID: O20040115000409 |
News Archive
BioCryst Pharmaceuticals, Inc. announced the presentation of new data that confirms forodesine's clinical activity in the treatment of chronic lymphocytic leukemia at the 52nd Annual American Society of Hematology Meeting & Exposition being held in Orlando, Florida.
A government report says that clinical trials for new medicines are taking too long and should be sped up so patients can access urgently needed treatment. The states and territories have been urged to adopt uniform rules on approving trials so the scientific experiments can be conducted more efficiently and effectively.
The states need to increase the number of public dental patients they treat or lose the reward payments offered by the federal government under its new $500 million dental package. A total of over $800 million of new money has come into the focal points of the health budget - dental and aged care.
Merck & Co., Inc., known outside the U.S. and Canada as MSD, today provided further detail on integration plans for the company's research and development, manufacturing and other business operations as part of a global restructuring program announced following the November 2009 merger of Merck and Schering-Plough.
A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.
› Verified 1 days ago
| Entity Name | Pulmonary & Critical Care Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598700932 PECOS PAC ID: 0547250607 Enrollment ID: O20040512001399 |
News Archive
BioCryst Pharmaceuticals, Inc. announced the presentation of new data that confirms forodesine's clinical activity in the treatment of chronic lymphocytic leukemia at the 52nd Annual American Society of Hematology Meeting & Exposition being held in Orlando, Florida.
A government report says that clinical trials for new medicines are taking too long and should be sped up so patients can access urgently needed treatment. The states and territories have been urged to adopt uniform rules on approving trials so the scientific experiments can be conducted more efficiently and effectively.
The states need to increase the number of public dental patients they treat or lose the reward payments offered by the federal government under its new $500 million dental package. A total of over $800 million of new money has come into the focal points of the health budget - dental and aged care.
Merck & Co., Inc., known outside the U.S. and Canada as MSD, today provided further detail on integration plans for the company's research and development, manufacturing and other business operations as part of a global restructuring program announced following the November 2009 merger of Merck and Schering-Plough.
A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kevin J Grady, MD 50505 Schoenherr Rd, Suite 290, Shelby Township, MI 48315-3140 Ph: (586) 314-0080 | Dr Kevin J Grady, MD 25319 Little Mack Ave, Saint Clair Shores, MI 48081-3370 Ph: (586) 772-5550 |
News Archive
BioCryst Pharmaceuticals, Inc. announced the presentation of new data that confirms forodesine's clinical activity in the treatment of chronic lymphocytic leukemia at the 52nd Annual American Society of Hematology Meeting & Exposition being held in Orlando, Florida.
A government report says that clinical trials for new medicines are taking too long and should be sped up so patients can access urgently needed treatment. The states and territories have been urged to adopt uniform rules on approving trials so the scientific experiments can be conducted more efficiently and effectively.
The states need to increase the number of public dental patients they treat or lose the reward payments offered by the federal government under its new $500 million dental package. A total of over $800 million of new money has come into the focal points of the health budget - dental and aged care.
Merck & Co., Inc., known outside the U.S. and Canada as MSD, today provided further detail on integration plans for the company's research and development, manufacturing and other business operations as part of a global restructuring program announced following the November 2009 merger of Merck and Schering-Plough.
A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.
› Verified 1 days ago
Jahnavi Chakrala, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 20229 E 9 Mile Rd Ste 200, Saint Clair Shores, MI 48080 Phone: 586-267-0200 Fax: 313-343-4412 | |
Kimberley Demerle, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 21000 E 12 Mile Rd Ste 112, Saint Clair Shores, MI 48081 Phone: 586-772-5550 Fax: 586-772-2470 | |
Maridel Aileen Hernandez, DO Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 19603 E 8 Mile Rd, Saint Clair Shores, MI 48080 Phone: 586-445-7900 Fax: 586-445-7940 | |
Daniel Shelden, DO Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 23715 Little Mack Ave Ste 100, Saint Clair Shores, MI 48080 Phone: 586-447-8021 Fax: 586-447-8022 | |
Dr. Demetrios Mermiges, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 19611 E 8 Mile Rd, Saint Clair Shores, MI 48080 Phone: 586-772-6850 Fax: 586-772-3810 | |
Zaid Kasmikha, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 24211 Little Mack Ave, Saint Clair Shores, MI 48080 Phone: 586-498-0440 Fax: 586-498-0429 | |
Dr. Marybeth Hardwicke, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 23411 Jefferson Ave, Suite 100, Saint Clair Shores, MI 48080 Phone: 586-778-4080 Fax: 586-778-6055 |